blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3603656

EP3603656 - PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF GYNECOLOGICAL DISEASES CONTAINING EXTRACT OF SARCODON IMBRICATUS AS ACTIVE INGREDIENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.07.2023
Database last updated on 02.11.2024
FormerExamination is in progress
Status updated on  28.10.2022
FormerRequest for examination was made
Status updated on  03.01.2020
FormerThe international publication has been made
Status updated on  29.09.2018
Most recent event   Tooltip07.07.2023Application deemed to be withdrawnpublished on 09.08.2023  [2023/32]
Applicant(s)For all designated states
Woo, Hye Jin
4 Obong 9-gil
Mulgeum-eup
Yangsan-si, Gyeongsangnam-do 50600 / KR
[2020/06]
Inventor(s)01 / WOO, Dae Ha
4 Obong 9-gil
Mulgeum-eup
Yangsan-si Gyeongsangnam-do 50600 / KR
02 / WOO, Hye Jin
4 Obong 9-gil
Mulgeum-eup
Yangsan-si Gyeongsangnam-do 50600 / KR
 [2020/06]
Representative(s)Lahrtz, Fritz, et al
Simmons & Simmons LLP
Lehel Carré Thierschplatz 6
80538 München / DE
[N/P]
Former [2020/06]Lahrtz, Fritz
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
Application number, filing date18770993.602.03.2018
[2020/06]
WO2018KR02529
Priority number, dateKR2017003716823.03.2017         Original published format: KR 20170037168
[2020/06]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018174424
Date:27.09.2018
Language:KO
[2018/39]
Type: A1 Application with search report 
No.:EP3603656
Date:05.02.2020
Language:EN
[2020/06]
Search report(s)International search report - published on:KR27.09.2018
(Supplementary) European search report - dispatched on:EP08.10.2020
ClassificationIPC:A61K36/07, A23L33/10, A23L31/15, A61P15/00
[2020/45]
CPC:
A23L31/15 (EP,KR); A61K36/07 (EP,CN,KR,US); A23L33/10 (EP,KR);
A23L33/105 (CN); A61K31/07 (EP); A61K31/197 (EP);
A61K31/355 (EP); A61K31/375 (EP); A61K31/4188 (EP);
A61K31/4415 (EP); A61K31/51 (EP); A61K31/519 (EP);
A61K31/525 (EP); A61K31/714 (EP); A61K33/06 (EP);
A61K33/10 (EP); A61K33/14 (EP); A61K33/26 (EP);
A61K33/30 (EP); A61K9/0056 (US); A61P15/00 (EP,CN);
A61P15/08 (US); A61P29/00 (CN); A23V2002/00 (EP,CN,KR);
A23V2200/30 (EP,KR); A23V2250/208 (EP,KR); A61K2236/331 (EP,CN);
A61K2236/333 (US); A61K2236/39 (CN); A61K2236/51 (CN);
A61K2236/53 (CN); Y02A50/30 (EP) (-)
C-Set:
A61K31/07, A61K2300/00 (EP);
A61K31/197, A61K2300/00 (EP);
A61K31/355, A61K2300/00 (EP);
A61K31/375, A61K2300/00 (EP);
A61K31/4188, A61K2300/00 (EP);
A61K31/4415, A61K2300/00 (EP);
A61K31/519, A61K2300/00 (EP);
A61K31/51, A61K2300/00 (EP);
A61K31/525, A61K2300/00 (EP);
A61K31/714, A61K2300/00 (EP);
A61K33/06, A61K2300/00 (EP);
A61K33/10, A61K2300/00 (EP);
A61K33/14, A61K2300/00 (EP);
A61K33/26, A61K2300/00 (EP);
A61K33/30, A61K2300/00 (EP);
A61K36/07, A61K2300/00 (EP);
A23V2002/00, A23V2200/30, A23V2250/208 (CN)
(-)
Former IPC [2020/06]A61K36/07, A23L33/10, A23L31/15
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/06]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON GYNÄKOLOGISCHEN ERKRANKUNGEN MIT EXTRAKT VON SARCODON IMBRICATUS ALS WIRKSTOFF[2020/06]
English:PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF GYNECOLOGICAL DISEASES CONTAINING EXTRACT OF SARCODON IMBRICATUS AS ACTIVE INGREDIENT[2020/06]
French:COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT PROPHYLACTIQUE OU THÉRAPEUTIQUE DE MALADIES GYNÉCOLOGIQUES CONTENANT UN EXTRAIT DE SARCODON IMBRICATUS EN TANT QUE PRINCIPE ACTIF[2020/06]
Entry into regional phase10.10.2019Translation filed 
10.10.2019National basic fee paid 
10.10.2019Search fee paid 
10.10.2019Designation fee(s) paid 
10.10.2019Examination fee paid 
Examination procedure10.10.2019Examination requested  [2020/06]
28.04.2021Amendment by applicant (claims and/or description)
02.11.2022Despatch of a communication from the examining division (Time limit: M04)
14.03.2023Application deemed to be withdrawn, date of legal effect  [2023/32]
04.04.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/32]
Fees paidRenewal fee
23.03.2020Renewal fee patent year 03
24.03.2021Renewal fee patent year 04
28.02.2022Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.202306   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]JP2000355547  ;
 [XY]KR20150089188  ;
 [XY]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2001, no. 23, Database accession no. 2001-220637, XP002800506 & JP2000355547 A 20001226 (MAEDA M) [X] 1-12 * abstract * [Y] 1-12
 [XY]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2015, no. 55, Database accession no. 2015-46334N, XP002800508 & KR20150089188 A 20150805 (UNIV DAEGU CATHOLIC IND ACAD COOP FOUND) [X] 1-12 * abstract * [Y] 1-12
 [XY]  - SULKOWSKA-ZIAJA KATARZYNA ET AL, "Chemical composition and cytotoxic activity of the polysaccharide fractions in Sarcodonimbricatus (Basidiomycota)", vol. 47, no. 1, doi:10.5586/AM.2012.006, ISSN 0001-625X, (20120101), pages 49 - 56, ACTA MYCOLOGICA, PANSTWOWE WYDAWNICTWO NAUKOWE, WARZAW, PL, URL: https://pbsociety.org.pl/journals/index.php/am/article/viewFile/2647/2200, (20131223), XP009523166 [X] 1-12 * the whole document * [Y] 1-12

DOI:   http://dx.doi.org/10.5586/am.2012.006
 [Y]  - BAE JUN-TAE ET AL, "Preventive Effect of Sarcodon aspratus Extract on the Liver Damage in B(a)P-Treated Mice", JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, KOREAN INTELLECTUAL PROPERTY OFFICE, (20010428), vol. 30, no. 2, ISSN 1226-3311, pages 320 - 324, XP053025678 [Y] 1-12 * abstract *
International search[A]KR20150089188  (CATHOLIC UNIV DAEGU INDUSTRY ACADEMIC COOPERATION FOUNDATION [KR])[A] 1-10, 12;
 [A]KR20160058270  (HEO TAE HO [KR]) [A] 1-10, 12;
 [A]KR20170028486  (UNIV HOSEO ACAD COOP FOUND [KR]) [A] 1-10, 12;
 [A]  - KANG Hee Chol et al., "Chemical Structures of the Compounds Isolated from edible Mushroom Sarcodon Asparatus", Journal of Korean Agricultural Chemical Society, (20000000), vol. 43, no. 4, pages 298 - 302, XP053020959 [A] 1-10, 12 [A] 1-10, 12
by applicantKR20150005430
 KR101598283B
    - Merck Index, Merck & Co., Inc.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.